These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30 related articles for article (PubMed ID: 7539634)
1. Does a Better Perfusion of Deconditioned Muscle Tissue Release Chronic Low Back Pain? Valdivieso P; Franchi MV; Gerber C; Flück M Front Med (Lausanne); 2018; 5():77. PubMed ID: 29616222 [TBL] [Abstract][Full Text] [Related]
2. T/T homozygosity of the tenascin-C gene polymorphism rs2104772 negatively influences exercise-induced angiogenesis. Valdivieso P; Toigo M; Hoppeler H; Flück M PLoS One; 2017; 12(4):e0174864. PubMed ID: 28384286 [TBL] [Abstract][Full Text] [Related]
3. Differential expression of genes in cells cultured from juxtacanalicular trabecular meshwork and Schlemm's canal. O'Brien ET; Wang Y; Ying H; Yue BY J Ocul Pharmacol Ther; 2014; 30(2-3):291-9. PubMed ID: 24611521 [TBL] [Abstract][Full Text] [Related]
4. Tenascin expression in primary and recurrent breast carcinomas and the effect of tenascin on breast tumor cell cultures. Tokés AM; Paku S; Tóth S; Paál E; Kulka J; Tóth J; Telekes A Pathol Oncol Res; 2000; 6(3):202-9. PubMed ID: 11033461 [TBL] [Abstract][Full Text] [Related]
5. Regulation of tenascin-C, a vascular smooth muscle cell survival factor that interacts with the alpha v beta 3 integrin to promote epidermal growth factor receptor phosphorylation and growth. Jones PL; Crack J; Rabinovitch M J Cell Biol; 1997 Oct; 139(1):279-93. PubMed ID: 9314546 [TBL] [Abstract][Full Text] [Related]
6. Stromal tenascin distribution as a prognostic marker in colorectal cancer. Kressner U; Lindmark G; Tomasini-Johansson B; Bergström R; Gerdin B; Påhlman L; Glimelius B Br J Cancer; 1997; 76(4):526-30. PubMed ID: 9275031 [TBL] [Abstract][Full Text] [Related]
7. Tenascin-C, proliferation and subendothelial fibronectin in progressive pulmonary vascular disease. Jones PL; Cowan KN; Rabinovitch M Am J Pathol; 1997 Apr; 150(4):1349-60. PubMed ID: 9094991 [TBL] [Abstract][Full Text] [Related]
8. Mitogenesis, cell migration, and loss of focal adhesions induced by tenascin-C interacting with its cell surface receptor, annexin II. Chung CY; Murphy-Ullrich JE; Erickson HP Mol Biol Cell; 1996 Jun; 7(6):883-92. PubMed ID: 8816995 [TBL] [Abstract][Full Text] [Related]
9. Neointima formation after acute vascular injury. Role of counteradhesive extracellular matrix proteins. Majesky MW Tex Heart Inst J; 1994; 21(1):78-85. PubMed ID: 7514061 [TBL] [Abstract][Full Text] [Related]
10. Expression of tenascin during carcinogenesis and involution of hormone-dependent tissues. Vollmer G Biochem Cell Biol; 1994; 72(11-12):505-14. PubMed ID: 7544587 [TBL] [Abstract][Full Text] [Related]
11. Functional aspects of vascular tenascin-C expression. Hahn AW; Kern F; Jonas U; John M; Bühler FR; Resink TJ J Vasc Res; 1995; 32(3):162-74. PubMed ID: 7539634 [TBL] [Abstract][Full Text] [Related]
12. Expression of tenascin by vascular smooth muscle cells. Alterations in hypertensive rats and stimulation by angiotensin II. Mackie EJ; Scott-Burden T; Hahn AW; Kern F; Bernhardt J; Regenass S; Weller A; Bühler FR Am J Pathol; 1992 Aug; 141(2):377-88. PubMed ID: 1379781 [TBL] [Abstract][Full Text] [Related]